A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP)

Biomedicine and Pharmacotherapy

Volumn 40, Issue 10, 1986, Pages 372-376

  Mathe G ^a   Kidani, Y ^a   Triana, K ^a   Brienza, S ^b   Ribaud, P ^b   Goldschmidt, E ^b   Ecstein, E ^b   Despax, R ^b   Musset, M ^b   Misset, J L ^b  

^a HÔPITAL PAUL BROUSSE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; OXOPLATIN;

ADVERSE DRUG REACTION; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG DOSE; DRUG THERAPY; DRUG TOXICITY; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CANCER; LUNG CANCER; MELANOMA; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THERAPY; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BLOOD CELL COUNT; DRUG EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ORGANOPLATINUM COMPOUNDS;

EID: 0022910291     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)